Langerhans cell histiocytosis natural history: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 15: | Line 15: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Revision as of 12:30, 24 August 2015
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis natural history On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis natural history |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis natural history |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Prognosis
- Excellent for single foci disease.
- With multifocal disease 60% have a chronic course, 30% achieve remission and mortality is up to 10%[1].